2026
Publications
2025
Posters
- Overview of Campylobacter spp. bone and joint infection in French reference centers
- Efficacy and safety of dalbavancin as suppressive therapy
2024
Posters
2023
Publications
Posters
- Diagnostic, management and outcome of bone flap osteomyelitis following craniectomy: a cohort study
- Risk factors, management and outcome of early (<6 months) open fracture-related infections (FRI)
2022
Publications
- Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
- Necrotizing external otitis: analysis of relapse risk factors in 66 patients managed during a 12 year period
2021
Communications orales
Posters
2020
Publications
- Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
- Tolerance and Microbiological Efficacy of Cefepime or piperacillin/tazobactam in Combination With Vancomycin as Empirical Antimicrobial Therapy of Prosthetic Joint Infection: A Propensity-Matched Cohort Study
- Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France
Posters
2019
Posters
- Tolerance and microbiological efficacy cefepim or piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of PJI
- Comparison of tolerance and microbiological efficacy of cefepim and piperacillin/tazobactam in combination with vancomycin as empirical antimicrobial therapy of prosthetic joint infection: a propensity-matched cohort study
- Comparaison de deux modèles pharmacocinétiques pour le suivi thérapeutique de la daptomycine
- Implementation and validation of a pharmacokinetic model for Bayesian therapeutic drug monitoring of daptomycin in patients with bone and joint infection
- Pharmacocinétique de la daptomycine dans les infections ostéo-articulaires : intérêt du suivi thérapeutique pharmacologique et de l’individualisation posologique
- Pseudomonas aeruginosa implant-associated Bone and Joint Infections : Experience in a Regional Reference Center in France
Publications
- Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients
- Pubic osteomyelitis: Epidemiology and factors associated with treatment failure
- Genetic polymorphisms of ABCB1 (P-glycoprotein) as a covariate influencing daptomycin pharmacokinetics: a population analysis in patients with bone and joint infection
- Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study
2018
Posters
- Evaluation de l’utilisation de la céfoxitine en association en administration parentérale continue dans le traitement des infections ostéo-articulaires
- Staphylococcal acute post-operative prosthetic joint infection (PJI) treated with ‘DAIR’ (debridement and implant retention) and impact of rifampin: a retrospective cohort study in France
Publications
- Prospective Cohort Study of the Tolerability of Prosthetic Joint Infection Empirical Antimicrobial Therapy
- Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
- Outpatient parenteral antibiotic therapy: Evaluation of practices and limits of use in rural areas in France
- Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy
Cas cliniques
Communications orales
2017
Posters
- Pressure ulcer-related pelvic osteomyelitis : Evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy
- Microbiological epidemiology depending on time to occurrence of prosthetic joint infection (PJI) : impact on the empirical antimicrobial strategies
- Corynebacterium bone and joint infection (BJI): A retrospective cohort from a BJI reference center
- Subcutaneous Suppressive Antibiotic Therapy for Bone and Joints Infections: Safety and Outcome in a Cohort of 10 Patients
Communications orales
- Evénements indésirables de l’antibiothérapie probabiliste au cours des infections sur prothèse articulaire: Etude prospective sur 5 ans
- Délai de survenue et épidémiologie bactérienne des infections sur prothèse articulaire : impact sur le choix de l’antibiothérapie probabiliste
- Adverse events (AE) during prosthetic joint infection (PJI) empirical antimicrobial therapy : a five year prospective cohort study